FDB (First Databank, Inc.), the leading provider of clinically robust, AI-enabled medication intelligence that helps healthcare professionals make precise medication decisions and streamline medication workflows, today announced the first commercial deployment of FDB Script Agent™, an AI prescribing agent that turns patient-visit dialogue into structured prescriptions ready for clinician review. The deployment with Tebra, an all-in-one technology platform for independent healthcare practices, brings FDB’s trusted medication intelligence into the ambient clinical workflow with clinical validation and terminology codification rather than simple NLP.
Script Agent uses FDB’s dose-appropriate medication intelligence to transform encounter dialogue into structured, evidence-based prescriptions for clinician review. Clinicians can modify or approve each prescription before it is sent. Due to its clinical grounding, the agent avoids hazards of simple NLP alone and will not stage prescriptions that fall outside normal prescribing practice without a clinician override.
Ambient AI has significantly reduced documentation burden by turning patient conversations into clinical notes, but prescribing often remains a manual task during or after the visit, and physician expectations are rising. FDB Script Agent extends ambient AI automation beyond documentation into prescribing by interpreting physician intent from the encounter and assembling the codified prescription elements needed by the EHR.
How FDB is Revolutionizing Prescribing Workflows
Tebra integrated Script Agent into its Tebra AI Note Assist, Tebra’s AI-powered clinical documentation workflow for independent ambulatory practices.
“Prescribing is one of the most important moments in care, but it still buries clinicians in administrative work,” said David Delaney, MD, president of FDB. “By capturing prescriptions directly from the ambient exam-room conversation and grounding them in FDB’s trusted medication intelligence, Script Agent turns that dialogue into a structured prescription ready for review. This lowers the administrative burden of prescribing while keeping clinicians in control.”
Early Tebra users report the AI Note Assist feature using Script Agent is intuitive and reduces prescribing-related administrative effort while preserving confidence in the review process.
“Independent practices are being asked to do more with fewer resources, and every minute spent on administrative work is time taken away from patient care,” said Kyle Ryan, Tebra chief product and technology officer. “We’re excited to partner with FDB to deliver AI-powered prescription review that simplifies prescribing workflows and reduces operational burden. These capabilities, as well as FDB’s trusted, clinically validated content, drove our decision to collaborate and help advance Tebra’s broader mission of equipping independent providers with advanced technology to make everyday healthcare operations more efficient and effective.”
Script Agent also supports FDB’s broader prescription intelligence strategy. Once a clinician approves a prescription, FDB Vela™, FDB’s cloud-native ePrescribing network, can help carry it through the next steps of the medication journey, connecting prescribers, payers, pharmacies and patients.
The Tebra deployment of Script Agent marks the first step in FDB’s broader roadmap for AI-powered prescription intelligence, designed to reduce administrative burden while keeping clinicians at the center of prescribing.
